Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

ALILAZTINI
Rx
Cancer & Blood Disorders

ALILAZTINI

Lazertinib
Generic (INN)
Lazertinib
Strength
80mg
Packaging
90 tablets/bottle
Indication
Targeted treatment for EGFR-mutated non-small cell lung cancer. (See package insert.)
Registration No.
06-LM-10029-26
Package Insert
English & Lao (PDF)

More in Cancer & Blood Disorders

View all →
Become a partner
EN·ລາວ·中文